Fennec Pharmaceuticals (FENC) Other Non Operating Income (2010 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Other Non Operating Income came in at -$2.0 million in Q4 2025, down 7488.89% YoY from $27730.8 in Q4 2024, and down 68200.0% on a QoQ basis from -$3000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) Other Non Operating Income (2010 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 16 years of Other Non Operating Income data on file, last reported at -$2.0 million in Q4 2025.
- Quarterly Other Non Operating Income fell 7488.89% year-over-year to -$2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.0 million (down 2365.85% YoY) and the FY2025 annual result came in at -$2.0 million, down 2365.85% from the prior year.
- Other Non Operating Income eased to -$2.0 million in Q4 2025, from -$3000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $17000.0 in Q2 2025 to a low of -$2.0 million in Q4 2025.
- A 5-year average of -$111473.7 and a median of -$3000.0 in 2022 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income soared 400.0% — and 2025, when it slumped 7488.89%.
- Tracing FENC's Other Non Operating Income over 5 years: stood at -$1000.0 in 2021, then slumped by 200.0% to -$3000.0 in 2022, then surged by 166.67% to $2000.0 in 2023, then plunged by 1450.0% to -$27000.0 in 2024, then tumbled by 7488.89% to -$2.0 million in 2025.
- The last three Other Non Operating Income figures came in at -$2.0 million (Q4 2025), -$3000.0 (Q3 2025), and $17000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6,000.00 |
| Dec 31, 2025 | -2.05 Mn |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | -27,000.00 |
| Jun 30, 2024 | -17,000.00 |
| Mar 31, 2024 | -38,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | -11,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | -4,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Jun 30, 2021 | -4,000.00 |
| Mar 31, 2021 | -4,000.00 |